HotSheets 2009

Diagnoses of Cancer Decline in the US
Cleveland Clinic Unveils ‘Top 10’ Medical Innovations for 2009
Antidiabetic Drugs Linked to Lower Risk of Prostate Cancer
Index of Articles Appearing in the 2008 Us TOO HotSheets
Doc Moyad’s “What Works and What Is Worthless Column”— The JUPITER trial
PSA Doubling Time and Time to Biochemical Failure May Predict Prostate Cancer-Specific Mortality
Read more..

Us TOO Names 2009 Board Officers & Members
FDA Approves Ferring Pharmaceuticals’ Degarelix (generic name) for Advanced Prostate Cancer
Geography’s Role in Medicare Cancer Coverage
Low-Income Men More Often Diagnosed with Advanced Prostate Cancer
FDA Commissioner to Step Down
Us TOO Pleasanton, California Chapter Honors Memory of Bill Stone
The Doctor’s Note—Dr. Gerald Chodak
Read more..

Stop PSA Screening in Men Over 75 — But Only Those With Low PSA, Says New Study
Researchers Identify Biomarker for Fatal Prostate Cancer
Costs Force Cancer Survivors to Pass on Health Care
Molecule’s Prevalence May Aid in Deciding Whether to Treat Prostate Cancer
GTx Announces Phase III Clinical Development of Toremifene 20 mg on Course Following Safety Review
Preventing Prostate Cancer: Good Nutrition May Be Key
Personalized Calculator for Future Prostate Cancer Risk
Read more..

What to Make of the Prostate Cancer Screening Studies
A Joint Statement from America’s Prostate Cancer Advocacy, Education and Support Organizations
Leading US-Based Prostate Cancer Organizations Develop Joint Policy Agenda
PSA Has Higher Predictive Ability in Black Men than in White Men
Highlights from the 2009 ASCO GU Cancers Symposium
Selected Men with Low-Risk Prostate Cancer Have Good Clinical Outcomes without Immediate Treatment
The Doctor’s Note — Dr. Gerald Chodak
Read more..

Signposts Brochure Now Available
Young Men with Advanced Cancer & Prognosis
False Positives in Screening Reduced by New Test
Predicting Prostate Cancer Recurrence
Combidex® & Lymph Node Metastasis
Us TOO Seeks Board Member Applications
Prostate Cancer Yet Another Worry for Women
Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
Read more..

New Urinary Continence Brochure Available
Prostate Cancer Patients Should Not Take Selenium
Test Improves Prediction of Disease Course
Predicting the Return of Prostate Cancer
Prostate Cancer Screening: A Question of Common Sense — Dr. Louis Denis, Us TOO Belgium
Men with Post-RP pT3 Disease & An Undetectable PSA Benefit from Adjuvant Radiation Therapy
Prostate Shrinkage May Reveal High-Grade Cancer
Read more..

Special Burning Issues Supplement: Identifying Clinically Significant Prostate Cancers
PCAM Activities
Study Finds Acceptable Levels of Anxiety in Men Living with Early, Untreated Prostate Cancer
Heavy Drinking Boosts Prostate Cancer Risk
Prostatectomy May Not Always Be Necessary
Awareness of Prostate Cancer in the General Public
Some Cancer Rates Higher in the Military
HIFU in the Treatment of Primary Prostate Cancer
Read more..

Denosumab Prevents Fractures in Men with Non-Metastatic Prostate Cancer Receiving ADT
Coronary Artery Disease Risks with ADT
FDA Issues Final Rules to Help Patients Gain Access to Investigational Drugs
‘Watchful Waiting’ Is a Viable Option for Prostate Cancer Patients with Low-Risk Tumors
PET/CT Scans May Help Detect Recurring Prostate Cancer Earlier
Robotic Surgery May Improve Functional Outcome
Larry King Live Video Discusses Early Detection of Prostate Cancer Using the PSA Test
Doc Moyad’s “What Works and What Is Worthless Column”— Coenzyme Q10
Read more..

Link Found Between Common Sexual Infection and Risk of Aggressive Prostate Cancer
Every Mustache Makes a Difference
New Web-Based Us TOO Prostate Cancer Support Community
Soy Pills Fail to Prevent Bone Loss
Men Diagnosed with Prostate Cancer in Recent Years Have Better Survival Outcomes
Getting Closer to the Origins of Prostate Cancer
Protein Tied with Aggressive Prostate Cancer
5th Annual Chicago SEA Blue Prostate Cancer Walk
Doc Moyad’s “What Works and What Is Worthless Column”— For BPH, Drugs Are Better than Herbs
Read more..

Doc Moyad’s “No Bogus Science” Column—Why I Donate to Us TOO International
AUA Releases Statement Clarifying Prostate Cancer Testing Recommendations
Dendreon Completes Submission of Biologics License Application for PROVENGE®
Questions on Breast & Prostate Cancer Screening
American Cancer Society Stands by its Screening Guidelines; Mammograms for Women Encouraged
FDA Says No to Amgen Bone Drug
Radical Prostatectomy Finding in Patients Who Fail Active Surveillance for Prostate Cancer
Clinicians Map Group at High Risk for Aggressive “Hidden” Prostate Cancer
Read more..

Patient Support Hotline